An implantable device comprising a nanochanneled membrane is described. The device uses nanofluidics to control the delivery of diagnostic and/or therapeutic agents intratumorally. The devices can be used for chemotherapy, radiosensitization, immunomodulation, and imaging contrast.
|Original language||English (US)|
|IPC||A61M 37/ 00 A I|
|State||Published - May 10 2018|